Elmer Song

Pulmonary Rare Disease Key Account Leader- KAL at Johnson & Johnson Innovative Medicine | Lake Grove, New York, United States

About Elmer Song

Elmer Song currently serves as the Pulmonary Rare Disease Key Account Leader for Johnson & Johnson Innovative Medicine, where he plays a pivotal role in promoting Opsumit and Uptravi, two critical therapies for the treatment of pulmonary arterial hypertension (PAH). With a focus on the Long Island, Queens, Brooklyn, and Staten Island regions, Elmer is responsible for engaging with key academic centers, hospitals, and clinics to ensure that healthcare professionals are well-informed about these innovative treatment options. His extensive experience in the biopharmaceutical and biotech sectors, spanning over 25 years, has equipped him with a unique blend of strategic thinking and business acumen that drives successful product positioning and sales growth.

Elmer's multi-award-winning track record is a testament to his ability to transform both new and existing products into market leaders. His expertise in business analysis and cross-functional coordination allows him to effectively navigate the complexities of the healthcare landscape, ensuring that his sales teams are not only equipped with the right tools but are also motivated to excel in a fiercely competitive environment. His background in dermatology, coupled with his deep understanding of pulmonary rare diseases, enables him to communicate effectively with a diverse range of stakeholders, from clinicians to decision-makers, fostering strong relationships built on trust and mutual respect.

In addition to his sales prowess, Elmer is known for his innovative approach to business strategy and his commitment to continuous improvement. His interpersonal communication skills and ability to set personal boundaries contribute to a collaborative work environment that encourages creativity and innovation. As he continues to lead initiatives that enhance patient access to life-changing therapies, Elmer Song remains a key figure in advancing the treatment landscape for pulmonary arterial hypertension.

Elmer Song Work